Lisa Rojkjaer
Chief Medical Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Medical Officer | — | — |
| 2022 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Medical Officer | — | — |
Earnings-call appearances
-
Rigel Pharmaceuticals, Inc. VEPPANU (vepdegestrant) Licensing Agreement Conference Call2026-05-12
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q1 FY2026 Earnings Call2026-05-05
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q3 FY2025 Earnings Call2025-11-04
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q2 FY2025 Earnings Call2025-08-05
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q1 FY2025 Earnings Call2025-05-06
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q4 FY2024 Earnings Call2025-03-04
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q3 FY2024 Earnings Call2024-11-07
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q2 FY2024 Earnings Call2024-08-06
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q1 FY2024 Earnings Call2024-05-07
Rigel Pharmaceuticals Inc (RIGL)